Bruker (BRKR) FCF Margin Growth (1y) (2011 - 2026)
Bruker (BRKR) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | -1,716.00 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -125.00 |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 2,833.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | 2,811.00 |
| 10 | Bruker | 9.25 Bn | 9.25 Bn | 379.80 Mn | 84.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.00 |
| Dec 31, 2025 | -2,414.00 |
| Sep 30, 2025 | -696.00 |
| Jun 30, 2025 | -1,573.00 |
| Mar 31, 2025 | 481.00 |
| Dec 31, 2024 | -471.00 |
| Sep 30, 2024 | -164.00 |
| Jun 30, 2024 | -140.00 |
| Mar 31, 2024 | -906.00 |
| Dec 31, 2023 | 104.00 |
| Sep 30, 2023 | 47.00 |
| Jun 30, 2023 | 905.00 |
| Mar 31, 2023 | -76.00 |
| Dec 31, 2022 | 320.00 |
| Sep 30, 2022 | 60.00 |
| Jun 30, 2022 | -1,047.00 |
| Mar 31, 2022 | -333.00 |
| Dec 31, 2021 | -1,164.00 |
| Sep 30, 2021 | -1,142.00 |
| Jun 30, 2021 | 188.00 |